Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Recruiting 2Terminated 1Completed 1

Sponsor Class

OTHER 1

Study Type

Interventional 1

Sponsor

Cancer Type

Lymphoid 26Other hematologic neoplasm 13Myeloid 8Dermatologic 8Plasma cell 7CNS 3Sarcoma 2Other neoplasm 2Classical hematology 2Genitourinary 1

Conditions

Prostatic Neoplasms 595Carcinoma, Renal Cell 276Urinary Bladder Neoplasms 175Kidney Neoplasms 112Neoplasms 101Neoplasm Metastasis 94Carcinoma, Non-Small-Cell Lung 94Carcinoma, Transitional Cell 86Melanoma 85Breast Neoplasms 83Ovarian Neoplasms 64Lung Neoplasms 50Colorectal Neoplasms 50Pancreatic Neoplasms 43Stomach Neoplasms 40Sarcoma 37Squamous Cell Carcinoma of Head and Neck 35Triple Negative Breast Neoplasms 31Testicular Neoplasms 29Uterine Cervical Neoplasms 27Esophageal Neoplasms 26Carcinoma, Hepatocellular 26Head and Neck Neoplasms 24Non-Muscle Invasive Bladder Neoplasms 23Small Cell Lung Carcinoma 22Colonic Neoplasms 20Urologic Neoplasms 17Neuroblastoma 17Multiple Myeloma 17Endometrial Neoplasms 17

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Terminated × Lymphoproliferative Disorders × Genitourinary × Clear all
NCT01435356 2019-01-09

MAGNOLIA

European Association of Urology Research Foundation

Phase 2 Terminated
83 enrolled 18 charts
GenitourinaryLymphoid

Urinary Bladder Neoplasms, Immune System Diseases, Lymphoproliferative Disorders

Data powered by HemOnc (CC BY 4.0) Colophon âš¡